| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/10/2009 | US20090228996 Means and Methods for influencing Interactions Between Dc-Sign and Dc-Sign Ligands |
| 09/10/2009 | US20090228994 Antibody Composition-Producing Cell |
| 09/10/2009 | US20090227779 Dry hemostatic compositions and methods for their preparation |
| 09/10/2009 | US20090227772 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 09/10/2009 | US20090227770 Polypeptide carrier protein |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227663 Inhibition of tumor growth and invasion by anti matrix metalloproteinases dnazymes |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227660 GLP-1 gene delivery for the treatment of type 2 diabetes |
| 09/10/2009 | US20090227535 Process for producing natural immunobiotic extract and uses thereof |
| 09/10/2009 | US20090227522 Targeted Delivery of Pharmaceutical Compounds |
| 09/10/2009 | US20090227521 Use of compounds in the treatment of ischemia and neurodegeneration |
| 09/10/2009 | US20090227520 Treatment methods using peptides related to amyloid precursor protein |
| 09/10/2009 | US20090227519 Compounds for control of appetite |
| 09/10/2009 | US20090227518 Compositions and methods for treating actin-mediated medical conditions |
| 09/10/2009 | US20090227517 Myostatin binding agents |
| 09/10/2009 | US20090227516 Compound comprising an autoantigenic peptide and a carrier with a mhc binding motif |
| 09/10/2009 | US20090227515 Peptide Inhibition of Lung Epithelial Apoptosis and Pulmonary Fibrosis |
| 09/10/2009 | US20090227514 Method and composition using irvingia gabonensis for reducing body weight |
| 09/10/2009 | US20090227513 Treating eye disorders using intestinal trefoil proteins |
| 09/10/2009 | US20090227512 Methods and compositions for treating and preventing distal bowel lesions |
| 09/10/2009 | US20090227511 Methods and compositions for treating lesions of the respiratory epithelium |
| 09/10/2009 | US20090227510 Induction of tumor immunity by variants of folate binding protein |
| 09/10/2009 | US20090227509 Modulation of hiv replication by rna interference |
| 09/10/2009 | US20090227508 Peptides that bind to the erythropoietin receptor |
| 09/10/2009 | US20090227507 Angiotensin (1-7) Dosage Forms and Uses Thereof |
| 09/10/2009 | US20090227506 Use of defensins against tuberculosis |
| 09/10/2009 | US20090227505 Methods and uses for protein breakdown products |
| 09/10/2009 | US20090227504 Pegylated Factor VII Glycoforms |
| 09/10/2009 | US20090227503 Parathyroid hormone treatment for enhanced allograft and tissue-engineered reconstruction of bone defects |
| 09/10/2009 | US20090227502 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227500 Genes affecting human memory performance |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227498 administering storage-stable composition containing a parathyroid hormone-related protein; for parenteral administration |
| 09/10/2009 | US20090227497 Variant activin receptor polypeptides and uses thereof |
| 09/10/2009 | US20090227496 Method of Producing Recombinant TAT-HOXB4H Protein for Use as a Stimulant of Hematopoiesis In Vivo |
| 09/10/2009 | US20090227495 Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof |
| 09/10/2009 | US20090227494 Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof |
| 09/10/2009 | US20090227493 Combined drug for treating diabetes |
| 09/10/2009 | US20090227492 TREATMENT OF NEUROLOGICAL CONDITIONS USING COMPLEMENT C5a RECEPTOR MODULATORS |
| 09/10/2009 | US20090227491 Antiviral phosphinate compounds |
| 09/10/2009 | US20090227490 Antitumoral Treatments |
| 09/10/2009 | US20090227489 STAT3 Agonists and Antagonists and Therapeutic Uses Thereof |
| 09/10/2009 | US20090227488 Class of bioactive glycoprotein |
| 09/10/2009 | US20090227487 Methods for the control of macrophage-associated inflammation |
| 09/10/2009 | US20090227468 Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes |
| 09/10/2009 | US20090227022 Growth factor homolog zvegf4 |
| 09/10/2009 | US20090227017 Nucleic acids encoding receptor for il-17 homologous polypeptides and uses thereof |
| 09/10/2009 | US20090227014 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/10/2009 | US20090227002 Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 09/10/2009 | US20090226942 Modified aerolysin and methods of use for treating lung cancer |
| 09/10/2009 | US20090226930 Beta cell antigen |
| 09/10/2009 | US20090226542 Fitness and exercise-enhancing tablet containing protein isolate |
| 09/10/2009 | US20090226532 biodegradable block copolymer constructed from poly(ethylene glycol)-terephthalate and poly(butylene terephthalate), a preferred therapeutic compound is alpha-interferons; sustained release; in-situ gelation; alpha interferons are released in monomeric, non-aggregated form |
| 09/10/2009 | US20090226530 Powdered protein compositions and methods of making same |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226520 Medical composition employing nanostructures |
| 09/10/2009 | US20090226519 Hydrogel bioscaffoldings and biomedical device coatings |
| 09/10/2009 | US20090226508 Methods And Materials For Immunization Against Cancer |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226499 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same |
| 09/10/2009 | US20090226484 Immunogenic LHRH compositions and methods relating thereto |
| 09/10/2009 | US20090226479 Vaccines and their use |
| 09/10/2009 | US20090226477 Pth2 receptor selective compounds |
| 09/10/2009 | US20090226475 Peptide-based immunization therapy for treatment of atherosclerosis |
| 09/10/2009 | US20090226473 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226468 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS |
| 09/10/2009 | US20090226467 De novo synthesis of bacteriochlorins |
| 09/10/2009 | US20090226463 Novel method of modulating bone-related activity |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226456 screening methods for identifying agonists and antagonists of TNFR-6 alpha & -6 beta activity; diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders; cancer |
| 09/10/2009 | US20090226454 Antibodies against a peptide epitope of apoliporotein b |
| 09/10/2009 | US20090226452 Method for enhancing or inhibiting insulin-like growth factor-i |
| 09/10/2009 | US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 09/10/2009 | US20090226450 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226446 Method to Inhibit the Propagation of an Undesired Cell Population |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226427 Novel pharmaceutical compositions for modulating angiogenesis |
| 09/10/2009 | US20090226426 Method for treating inflammation |
| 09/10/2009 | US20090226425 Diagnostics and Therapeutics For Glaucoma |
| 09/10/2009 | US20090226424 Subdermal tissue remodeling using myostatin, methods and related systems |
| 09/10/2009 | US20090226423 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/10/2009 | US20090226417 Human B7 polypeptides |
| 09/10/2009 | US20090226416 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 09/10/2009 | US20090226415 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/10/2009 | US20090226414 Method for detecting infectious parvovirus in pharmaceutical preparations |
| 09/10/2009 | US20090226413 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226412 Agent for reduction of bleeding in cerebrovascular disorder |
| 09/10/2009 | US20090226411 Chemical derivatives and their application as antitelomerase agents |
| 09/10/2009 | US20090226410 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226409 Pharmaceutical Compositions Comprising Sods and Prolamine Based Peptide Fragments |
| 09/10/2009 | US20090226408 Anti-fatigue composition |
| 09/10/2009 | US20090226407 Methods of treating vascular diseases characterized by nitric oxide insufficiency |